AG-1557 hydrochloride
CAS No.
AG-1557 hydrochloride ( —— )
Catalog No. M19479 CAS No.
AG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 49 | Get Quote |
|
10MG | 78 | Get Quote |
|
25MG | 155 | Get Quote |
|
50MG | 286 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAG-1557 hydrochloride
-
NoteResearch use only not for human use.
-
Brief DescriptionAG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
-
DescriptionAG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorhERG;EGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number--
-
Formula Weight443.66
-
Molecular FormulaC16H15ClIN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCl.COc1cc2ncnc(Nc3cccc(I)c3)c2cc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joshi A. Gadhwal M. and Joshi U.J. Indentification of potential novel EGFR inhibitors using a combination of pharmacophore and docking methods Int. J. Pharm. Pharmaceut. Sci. 7(6) (2015).
molnova catalog
related products
-
AZD-3759
A potent, oral active, BBB-penetrating EGFR inhibitor (IC50=7.2 nM, L858R pEGFR).
-
Lifirafenib
Lifirafenib is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant respectively.
-
CO-1686 hydrobromide
A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.